Article info

Download PDFPDF

Systematic review with meta-analysis
B-type natriuretic peptide-guided therapy for chronic heart failure reduces all-cause mortality compared with usual care but does not affect all-cause hospitalisation or survival free of hospitalisation
Free

Authors

  1. Correspondence to A Mark Richards
    Cardiovascular Research Institute, National University Heart Centre, Singapore 1 E Kent Ridge Road, NUHS Tower Block, Level 9, Singapore 119228; mdcarthu{at}nus.edu.sg
View Full Text

Citation

Richards AM
B-type natriuretic peptide-guided therapy for chronic heart failure reduces all-cause mortality compared with usual care but does not affect all-cause hospitalisation or survival free of hospitalisation

Publication history

  • First published August 5, 2010.
Online issue publication 
October 13, 2010

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.